Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Cell Biosciences, a provider of ultra sensitive protein detection and characterization systems to life science researchers, has appointed Jason Novi as its new CFO.
Subscribe to our email newsletter
Prior to joining Cell Biosciences, Mr Novi served as vice president of finance at Nektar Therapeutics.
The company has also appointed Robert Gavin as its new vice president of engineering, and Wilhelm Lachnit as vice president of R&D.
Most recently Mr Gavin served as director of engineering at MDS Analytical Technologies, and Dr Lachnit pioneered the early adoption of automated cell-based assays at Roche and Syntex.
Tim Harkness, president and CEO of Cell Biosciences, said: “These individuals have all been key contributors at successful life science companies. I am confident that they will provide exceptionally strong leadership as we develop our portfolio of ultra sensitive nano-proteomics products.”